Husam Alzayer Profile
Husam Alzayer

@Husamjz

Followers
480
Following
1K
Media
19
Statuses
352

#Nephrologist on a learning mission! #KIreports graphic designer, #NSMC #NephEdC faculty, and #NephJC team member

Joined December 2017
Don't wanna be here? Send us removal request.
@KIReports
KIReports
7 days
0
2
5
@ISNkidneycare
Int Society of Nephrology
1 month
📖 This weekend don't miss our @KIReports #ISNFridaySelection: Impact of Donor and Recipient Diabetes on Posttransplant Outcomes: Gradually Seeing the Wood for the Trees https://t.co/Dexzqlyl0V
0
6
10
@Husamjz
Husam Alzayer
1 month
Glad to share our case report of diffuse cortical necrosis in native kidneys of a patient with #sickle_cell_trait Although uncommon, patients with SCT can present with end-organ damage, and vigilance should be maintained when managing these patients https://t.co/VfrV86Srso
Tweet card summary image
karger.com
Abstract. Introduction: Sickle cell disorders are the most common hereditary hematological disorders; sickle cell trait (SCT) is largely benign with mild clinical manifestations, if any. Renal...
0
1
3
@KIReports
KIReports
2 months
Impact of Age-3 #Urine Screening on Diagnosis and Treatment Timing in #Alport #Syndrome #VisualAbstract by @Husamjz https://t.co/tKMvHCYFAC
0
5
11
@KIReports
KIReports
2 months
🧵Tweetorial Alert 🧵 1/ Hey #NephTwitter! Welcome to a 🆕 #tweetorial #xtorial brought to you by @KIReports.
1
4
5
@KIReports
KIReports
3 months
#Sex Differences Across #Corticosteroid Response and Outcomes in #IgA Nephropathy #VisualAbstract by @Husamjz https://t.co/xlgwrVgrLS
1
3
14
@KIReports
KIReports
3 months
0
5
11
@KIReports
KIReports
4 months
1
6
25
@KIReports
KIReports
5 months
#Japanese Patients’ Perceptions of Shared #DecisionMaking in Renal Replacement Therapy #RRT #VisualAbstract by @Husamjz https://t.co/3bF5DvXLA1
0
4
13
@fadelrowaie
Fadel Alrowaie
5 months
#فضفضة_طبيب بما ان هذه الفترة ، للتقديم على برامج التخصصات الدقيقة / الزمالات، يسألني الكثير ، عن تخصص طب الكلى ؟
1
2
6
@KIReports
KIReports
5 months
A Novel Perspective on Tubular #C4d Positivity in #BK #Polyomavirus Nephropathy #VisualAbstract by @Husamjz https://t.co/v4PhWPVyIp
0
9
21
@NephJC
Nephrology Journal Club
6 months
0
11
38
@NephJC
Nephrology Journal Club
6 months
👉We all need little nudges to do the right thing. Join us 6/24/25 on #Bluesky at 9pm EST as we chat about E-Nudges to improve goal directed medical therapy (GDMT) in CKD. #NephJC #NephTwitter Blog by @NephroSeeker @dra_miliflores @Husamjz https://t.co/mOwE55Bjxf
Tweet card summary image
nephjc.com
This week, we will discuss a registry trial: can a nationwide nudge fix a CKD treatment gap?
0
5
23
@KIReports
KIReports
7 months
The #Gut #Microbiome as a Risk Factor for Future Chronic Kidney Disease #CKD #VisualAbstract by @Husamjz https://t.co/XAAzAO70MV
1
4
16
@NephJC
Nephrology Journal Club
7 months
1/The unicorn is real! 🦄 Donor-specific antibodies with negative antibody-mediated rejection (DSA; AMR) exist. 1 in 4 rejection cases defy classic Banff 2022 dgn yet are associated with a 5-yr graft survival ⬇️ to 76%. Are we missing the silent 🔥? Welcome to #TenPostsNephJC
6
10
34
@NephJC
Nephrology Journal Club
2 years
1/10 Welcome to #TenTweetNephJC Did you sleep through our last chat? 😴 No worries, the 10 tweet #NephJC will get you all caught-up on SLEEP-HD 💤
1
14
22
@NephroSeeker
Cristina Popa 🦋
8 months
🤩Lots of interesting LBCT happening at #ERA25 in Vienna this year! 🎀4 sessions to be more exact ✨Hope to meet as many of you there
3
6
25
@NephJC
Nephrology Journal Club
8 months
✳️Welcome #TenTweets #NephJC ✳️ Metformin is one of the oldest medications for DM2 and is having a resurgence of use in people with inflammatory conditions. We stop when eGFR < 30, but what is the evidence that this is actually best for patient outcomes? https://t.co/OkQsCuFesj
1
10
22